Dermata Therapeutics Inc DRMA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 09/30/22 EDT
0.5201quote price arrow up+0.0001 (+0.02%)
Volume
46,773
52 week range
0.43 - 6.95
Loading...
  • Open0.5401
  • Day High0.55
  • Day Low0.5201
  • Prev Close0.52
  • 52 Week High6.95
  • 52 Week High Date11/03/21
  • 52 Week Low0.43
  • 52 Week Low Date06/16/22

Key Stats

  • Market Cap5.25M
  • Shares Out10.10M
  • 10 Day Average Volume0.18M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-70.11

KEY STATS

  • Open0.5401
  • Day High0.55
  • Day Low0.5201
  • Prev Close0.52
  • 52 Week High6.95
  • 52 Week High Date11/03/21
  • 52 Week Low0.43
  • 52 Week Low Date06/16/22
  • Market Cap5.25M
  • Shares Out10.10M
  • 10 Day Average Volume0.18M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-70.11

RATIOS/PROFITABILITY

  • EPS (TTM)-1.40
  • P/E (TTM)-0.37
  • Fwd P/E (NTM)-1.16
  • EBITDA (TTM)-9.782M
  • ROE (TTM)-269.92%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date11/15/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Dermata Therapeutics Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Dermata Therapeutics, Inc. is a clinical-stage medical dermatology company. The Company is focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its products candidates, DMT310 and DMT410. Its lead product candidate DMT310, is intended to utilize its Spongilla technology for a once weekly treatment of a variety of skin diseases with its initial focus being for the...
Gerald Proehl
Chairman of the Board, President, Chief Executive Officer
Kyri Van Hoose
Chief Financial Officer, Senior Vice President
Address
3525 Del Mar Heights Rd., #322
San Diego, CA
92130
United States

Top Peers

SYMBOLLASTCHG%CHG
PBLA
Panbela Therapeutics Inc
0.2703-0.0887-24.7075%
KRBP
Kiromic Biopharma Inc
0.29-0.0095-3.172%
ENVB
Enveric Biosciences Inc
4.22-0.09-2.09%
TENX
Tenax Therapeutics Inc
0.17-0.0142-7.709%
PRFX
PainReform Ltd
0.69+0.0609+9.68%